UK markets open in 6 hours 18 minutes

Outset Medical, Inc. (OM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.2500+0.0900 (+4.17%)
At close: 04:00PM EDT
2.2500 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 111.68M
Enterprise value 44.54M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.82
Price/book (mrq)0.91
Enterprise value/revenue 0.34
Enterprise value/EBITDA -0.29

Trading information

Stock price history

Beta (5Y monthly) 1.98
52-week change 3-87.89%
S&P500 52-week change 321.61%
52-week high 324.1300
52-week low 31.9200
50-day moving average 32.6958
200-day moving average 37.8351

Share statistics

Avg vol (3-month) 3980.78k
Avg vol (10-day) 31.32M
Shares outstanding 551.7M
Implied shares outstanding 651.7M
Float 849.64M
% held by insiders 13.97%
% held by institutions 1104.50%
Shares short (28 Mar 2024) 48.36M
Short ratio (28 Mar 2024) 47.11
Short % of float (28 Mar 2024) 419.48%
Short % of shares outstanding (28 Mar 2024) 416.55%
Shares short (prior month 29 Feb 2024) 48.09M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -132.54%
Operating margin (ttm)-122.44%

Management effectiveness

Return on assets (ttm)-29.73%
Return on equity (ttm)-93.69%

Income statement

Revenue (ttm)130.38M
Revenue per share (ttm)2.63
Quarterly revenue growth (yoy)-4.70%
Gross profit (ttm)N/A
EBITDA -163.96M
Net income avi to common (ttm)-172.8M
Diluted EPS (ttm)-3.4800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)203.32M
Total cash per share (mrq)4.03
Total debt (mrq)136.19M
Total debt/equity (mrq)110.83%
Current ratio (mrq)5.26
Book value per share (mrq)2.44

Cash flow statement

Operating cash flow (ttm)-131.37M
Levered free cash flow (ttm)-71.68M